Results 171 to 180 of about 7,531 (200)

[Recommendations for vaccination of adults for respiratory physicians]. [PDF]

Pneumologie
Ewig S, Hinze CA, Vogelmaier C, Stierl M, Rademacher J.   +4 more
europepmc   +1 more source

Recommandations relatives au vaccin antigrippal trivalent contenant l’adjuvant MF59 (Fluad®)

Relevé des maladies transmissibles au Canada, 2011
openaire   +1 more source

Progress and Recent Developments in HIV Vaccine Research. [PDF]

Vaccines (Basel)
Shim I, Rogowski L, Venketaraman V.
europepmc   +1 more source

Influenza A(H5N8) vaccine induces humoral and cell-mediated immunity against highly pathogenic avian influenza clade 2.3.4.4b A(H5N1) viruses in at-risk individuals. [PDF]

Nat Microbiol
Liedes O, Reinholm A, Ekström N, Haveri A, Solastie A, Vara S, Rijnink WF, Bestebroer TM, Richard M, de Vries RD, Jalkanen P, Lindh E, Ikonen N, Grifoni A, Sette A, Laaksonen T, Holopainen R, Kakkola L, Lappalainen M, Syrjänen RK, Kolehmainen P, Julkunen I, Nohynek H, Melin M.   +23 more
europepmc   +1 more source

Humoral responses to Cytomegalovirus glycoprotein B vaccine with MF59 adjuvant

, 2017
openaire   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Safety of MF59™ adjuvant

Vaccine, 2008
The need to enhance the immunogenicity of purified subunit antigens has prompted the development of new adjuvants. The adjuvant emulsion MF59 has been tested in animals in combination with different antigens and finally evaluated in humans. It was licensed after the successful outcome of preclinical and clinical testing.
Viola, Schultze, Vicente, D'Agosto, Andreas, Wack, Deborah, Novicki, Juergen, Zorn, Renald, Hennig   +5 more
openaire   +2 more sources

Biodistribution and mechanisms of action of MF59 and MF59-like adjuvants

Journal of Controlled Release
Recently, adjuvants have received increasing attention as essential vaccine components. Nearly 100 years have passed since Gaston Roman introduced the concept of adjuvants in 1925, during which numerous preclinical and clinical studies related to vaccine adjuvants have been conducted.
Wen, Zhang, Haicheng, Cui, Jixuan, Xu, Mingze, Shi, Lijun, Bian, Lili, Cui, Chunlai, Jiang, Yong, Zhang   +7 more
openaire   +2 more sources

Antigenically Distinct MF59-Adjuvanted Vaccine to Boost Immunity to H5N1

New England Journal of Medicine, 2008
The authors report on an open-label study of an MF59-adjuvanted vaccine against avian influenza.
Stephenson, I, Nicholson, KG, Hoschler, K, Zambon, MC, Hancock, K, DeVos, J, Katz, JM, Praus, M, Banzhoff, A   +8 more
openaire   +3 more sources